Synthesis Energy Systems (NASDAQ: SYMX) shares jumped 26.01% to $2.18 on the receipt of a 20-year business license for China Clean Coal Gasification joint venture
Prothena Corporation plc (NASDAQ: PRTA) rose 24.40% to $46.23 after the company reported clinical data to be presented at International Symposium on Amyloidosis. Morgan Stanley raised the price target on the stock from $35.00 to $53.00.
Horizon Pharma (NASDAQ: HZNP) shares gained 24.15% to $18.23 after the company announced its plans to acquire privately held Vidara Therapeutics International for around $660 million.
Pacific Sunwear of California (NASDAQ: PSUN) shares jumped 9% to $3.27 after the retailer reported upbeat Q4 results. The company posted an adjusted loss of $0.17 per share, versus analysts' expectations for a loss of $0.19 per share.
KB Home (NYSE: KBH) shares gained 8.99% to $19.27 after the company swung to a profit in the fiscal first quarter. KB Home posted a quarterly profit of $10.6 million, or $0.12 per share, versus a year-ago loss of $12.5 million, or $0.16 per share.
Top 5 Gas Utility Companies To Buy Right Now: Eco-Tek Group Inc (ETEK)
Eco-Tek Group, Inc., incorporated on April 10, 2007, is engaged in manufacturing and marketing of green lubricants and specialized systems with an automotive sector but also applicable to a variety of industrial, farm and virtually all mechanical equipment. The Company�� products include Eco-Tek Super Lubricant, Eco-Tek 3000 Synthetic Motor Oil, Eco-Tek 4-in-1 Fuel Treatments, Eco-Tek HD Synthetic Oil Stabilizer, Eco-Tek Bypass Oil Cleaner, Eco-Tek Engine Flush, Eco-Tek Lube Centres, Eco-Tek Test-Results, Eco-Tek Our Inventor and Eco-Tek Limited Warranty.
The Company�� motor oil and lubricant is zinc free. Eco-Tek Engine Flush which cleans internal engine components extends engine life and restores lost performance due to sludge and buildup. Eco-Tek Premium Orange Hand Cleaner, which contains pumice to clean, aloe and lanolin to moisturize. Eco-Tek Non-Toxic Super Lubricant, reduces friction, fuel consumption, harmful contaminants in oil, reduces smoke, vibration and noise.
Advisors' Opinion:- [By Peter Graham]
Small cap green stocks Eco-Tek Group Inc (OTCMKTS: ETEK) and BluForest Inc (OTCMKTS: BLUF) have been getting some attention lately thanks to some green���as in paid for promotions. Of course, there is nothing wrong with properly disclosed promotions, but one of these stocks happens to be getting a considerable amount of attention as its been the subject of numerous transactions. With that in mind, will investors see some green with these green small cap stocks? Here is a quick reality check:�
Top 5 Forestry Companies To Buy Right Now: mCig Inc (MCIG)
MCIG, INC. (mCig), incorporated on December 30, 2010, is a development-stage company. The Company is a technology company. The Company focused on two long-term secular trends sweeping the globe: the decriminalization and legalization of marijuana for medicinal or recreational purposes and the adoption of electronic vaporizing cigarettes (eCigs).
The mCig provides a smoking experience by heating (not burning) plant material, waxes, and oils delivering a smoother inhalation experience. As of October 31, 2013, the Company did not generate any revenues.
Advisors' Opinion:- [By John Udovich]
Last week, I talked about small cap electronic cigarette stocks Vapor Corp (OTCMKTS: VPCO) and Hop-On Inc (OTCMKTS: HPNN) as being among the last of the e-Cig�stocks not controlled by ��ig Tobacco,��but Victory Electronic Cigarettes Corp (OTCMKTS: ECIG), mCig Inc (OTCBB: MCIG) and American Heritage International (OTCBB: AHII)�are also�positioning themselves or their technology to exploit opportunities in the e-Cig market or even in�marijuana or cannabis. Last year, industry experts were already saying that�US retail sales of e-cigarettes could reach $1 billion for the year�for roughly�1% of the country's cigarette market. That number might appear small, but its more than double 2012 sales�as sales increasingly�move off the Internet and into more mainstream retailers thanks to their positioning as a���ealthier��alternative to smoking.
- [By Joel Elconin]
One such example is mCig (OTC: MCIG).
��CIG started off with a $10 vape pen," he said. "They almost envision themselves as being the Apple of the industry. CEO and founder Paul Rosenberg [is] strictly a businessman, he owns about half the stock. He then brought on some talent and gave them his stock to help the company. Why? Because he knows the stock is overvalued, but if you can [evolve a company] without diluting your shareholders, that's what I mean by doing the right thing.��/p>
- [By Jason Shubnell]
He also discussed MCIG (OTC: MCIG), a relatively new company that has developed a legal marijuana vaporizer, similar to the e-cig. The mCig heats plant material instead of burning it, providing a superior method of consumption that is much smoother, according to the company's website. The product sells for $10, while the stock itself has a market cap of $35 million.
- [By John Udovich]
After marijuana, the electronic cigarette sector and e-Cig stocks or industry players�like�Reynolds American, Inc (NYSE: RAI), mCig Inc (OTCBB: MCIG), Victory Electronic Cigarettes Corp (OTCMKTS: ECIG) and American Heritage International Inc (OTCBB: AHII) is looking like the next hot niche sector for investors. However, electronic cigarette stock investors should be aware of the following�recent good and bad news from the sector that needs to be digested:
Top 5 Forestry Companies To Buy Right Now: Tetraphase Pharmaceuticals Inc (TTPH)
Tetraphase Pharmaceuticals, Inc., incorporated on July 7, 2006, is a clinical stage biopharmaceutical company. The Company�� product candidate, eravacycline, is a fully synthetic tetracycline derivative that the Company are developing as a broad-spectrum intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of multi-drug resistant infections, including multi-drug resistant Gram-negative infections. The Company�� frequently used products, such as Zyvox and Cubicin, are limited to Gram-positive bacteria and thus are rarely used as a first-line empiric monotherapy if broad bacterial coverage is required. During the year ended December 31, 2012, completed a Phase 2 clinical trial of eravacycline with intravenous administration for the treatment of patients with complicated intra-abdominal infections, or cIAI, and are finalizing its pivotal Phase 3 program for eravacycline. In 2012, in vitro experiments, eravacycline has demonstrated the ability to cover a variety of multi-drug resistant Gram-negative, Gram-positive, anaerobic and atypical bacteria, including multi-drug resistant Klebsiella pneumoniae, the species of Gram-negative bacteria that killed seven patients at the Clinical Center of the National Institutes of Health.
Gram-positive bacteria that have developed resistance to existing drugs include: Streptococcus pneumoniae that cause pneumonia, ear infections, bloodstream infections and meningitis; Staphylococcus aureus that cause skin, bone, lung and bloodstream infections, and Enterococci that are responsible for infections transmitted in healthcare settings. Gram-negative bacteria that have developed resistance to existing drugs include: Escherichia coli that cause urinary tract, skin and bloodstream infections; Salmonella and Escherichia coli that cause foodborne infections, and Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella spp.
In addition, other antibiotics that have been used as first-line empiric monothe! rapies, such as Levaquin, piperacillin/tazobactam, which is marketed by Pfizer as Zosyn, carbapenems, such as Merrem, and imipenem/cilastatin, which is marketed by Merck as Primaxin, have seen their utility as first-line empiric monotherapies diminished as the number of bacterial strains resistant to these therapies has increased. In addition to developing an intravenous formulation of eravacycline, the Company is also developing an oral formulation. A number of previous tetracyclines have been available in both intravenous and oral dosage forms. Infections that are resistant to existing oral drugs are increasingly common, and the Company believe that an intravenous-to-oral step-down therapy in which patients are started on the intravenous formulation of eravacycline and then stepped down to an oral formulation of eravacycline could reduce the length of a patient�� hospital stay or help avoid hospital admission altogether, lowering the overall cost of care for these patients.
Advisors' Opinion:- [By Roberto Pedone]
Another under-$10 biopharmaceutical player that's starting to trend within range of triggering a near-term breakout trade is Tetraphase Pharmaceuticals (TTPH), which using its proprietary chemistry technology creates novel antibiotics for serious and life-threatening multi-drug resistant infections. This stock is off to a strong start in 2013, with shares up 19.4%.
If you take a look at the chart for Tetraphase Pharmaceuticals, you'll notice that this stock has just started to trend back above its 50-day moving average of $7.76 a share with decent upside volume flows. That move is quickly pushing shares of TTPH within range of breaking out above some key near-term overhead resistance levels that have acted as a ceiling for the stock for the last three months.
Market players should now look for long-biased trades in TTPH if it manages to break out above some near-term overhead resistance levels at $8.30 to $8.40 a share and then once it takes out more resistance at $8.50 to $9 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average volume of 62,234 shares. If that breakout triggers soon, then TTPH will set up to re-test or possibly take out its all-time high at $9.66 a share. Any high-volume move above that level will then push TTPH into new all-time high territory, which is bullish technical price action. Some possible upside targets off that move are $12 to $13 a share.
Traders can look to buy TTPH off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $7.76 a share, or below more key near-term support levels at $7.37 to $7.02 a share. One can also buy TTPH off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Top 5 Forestry Companies To Buy Right Now: RSC Holdings Inc.(RRR)
RSC Holdings Inc., together with its subsidiaries, engages in the rental of construction and industrial equipment primarily in the United States and Canada. It offers approximately 900 categories of equipment, including backhoes, forklifts, air compressors, scissor lifts, aerial work platform booms, and skid-steer loaders; and smaller items, such as pumps, generators, welders, and electric hand tools. The company also provides safety equipment, which comprise hard hats and goggles; consumables that include blades and gloves; tools comprising ladders and shovels; and other ancillary products. In addition, it sells new equipment; and used rental equipment, merchandise, and other related items. The company sells its products to industrial or non-construction related companies, and construction companies. As of December 31, 2011, it operated through a network of 440 rental locations in 43 states in the United States; and 3 Canadian provinces. The company is headquartered in Sc ottsdale, Arizona.
Advisors' Opinion:- [By Holly LaFon] s a machinery rental service for construction, industrial, petrochemical, governmental and manufacturing businesses in the U.S. and Canada. RSC tends to benefit in economic downturns, as more businesses turn to renting rather than buying equipment to cut costs. Rented equipment rose 20.7% percent (the sixth consecutive quarter of double-digit growth) and rental revenue increased 27% in the fourth quarter of 2011, compared to last year.
United Rentals (URI), one of RSC�� largest competitors, had a rental revenue increase of 18.5% in the fourth quarter compared to last year, which included a 6.7% increase in rental rates.
The company�� fleet utilization also increased to 69% for 2010, up 510 bps from 2010, and it spent $616 million in gross rental capital expenditures to keep up with demand.
Part of the growth is a result of management�� decision in 2006 to expand beyond the cyclical construction market to the largely untapped non-construction and industrial markets that need machinery for mining and oil and gas drilling.
RSC Holdings has a market cap of $2.26 billion; its shares were traded at around $22.15 with a P/E ratio of 197.91 and P/S ratio of 1.49.
Magma Design Automation Inc. (LAVA)
Magma Design Automation is a Silicon-Valley company that develops electronic design automation software products and solutions, from concept to completion. It has had relatively flat free cash flow growth for the last ten years and an average annual earnings growth of 1.8%.
On November 30, it announced it was going to be acquired by Synopsys Inc., for $7.35 per share, or $507 million net of cash and debt. Shareholders sued the company on December 1 saying that the sell price was too low, as it closed as high as $8.50 per share in July 2011 and analysts had set price targets at up to $11.00 per share.
Grantham bought 1,663,500 shares of the company at an average price of $5.70 in the fourth quarter.
Gold Fields Ltd.
No comments:
Post a Comment